Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001728117-23-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-03-22 | 2023-03-20 | GOSS | Giraudo Bryan | COO, CFO | P - Purchase | $0.97 | +50.0K | 71.0K | +238% | +$48.5K |
| D | 2023-03-22 | 2023-03-20 | GOSS | Giraudo Bryan | COO, CFO | A - Grant | $0.00 | +211.5K | 211.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | P | A | 50,000 | $0.97 | 70,990 | I By family trust | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-20 | A | A | 211,500 | $0.00 | 211,500 | D | $1.21 · — to 2033-03-19 | 211,500 Common Stock | (F1) 25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. |